Status:
ACTIVE_NOT_RECRUITING
Genetic Susceptibility to Bladder Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Bladder Cancer
Eligibility:
All Genders
Brief Summary
This clinical research study will identify biologic and lifestyle factors which increase a person's risk of developing specific cancer. Researchers propose to conduct a case-control study examining in...
Detailed Description
Researchers propose to conduct a case-control study examining interindividual differences in susceptibility to tobacco carcinogenesis as predictors of bladder cancer risk. We will measure susceptibili...
Eligibility Criteria
Inclusion
- Subject has a histologically confirmed diagnosis of superficial or muscle-invasive bladder cancer
- Subject is a Texas resident.
- Subject can understand English or a qualified translator is available for the interview.
- Subjects of any age, gender, or ethnicity are eligible to participate in the study.
- Subject consents to participate in the study.
Exclusion
- Subject has had prior treatment with systemic chemotherapy or radiotherapy in the past 6 months.
- Subject has been diagnosed with superficial or muscle-invasive bladder cancer more than twelve months ago.
Key Trial Info
Start Date :
February 10 1998
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2026
Estimated Enrollment :
6086 Patients enrolled
Trial Details
Trial ID
NCT00848289
Start Date
February 10 1998
End Date
August 1 2026
Last Update
August 1 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine
Houston, Texas, United States, 77030
2
MD Anderson Cancer Center
Houston, Texas, United States, 77030